Clinical Trials on Hormone Refractory Prostate Cancer in South Africa
Total 881 results
-
Bristol-Myers SquibbCompleted
-
MDx HealthTerminatedProstate CancerUnited States
-
Arvinas Androgen Receptor, Inc.RecruitingProstate Cancer MetastaticUnited States
-
Medical University of South CarolinaNational Cancer Institute (NCI)Active, not recruiting
-
EDAP TMS S.A.UnknownProstate CancerUnited States, Canada
-
St Vincent's Hospital, SydneyCompleted
-
University of MiamiJay L. Friedland MD Prostate Cancer Research FundRecruitingProstate CancerUnited States, Australia, Italy
-
AstraZenecaCompletedProstate CancerSweden, United States, Brazil, France, Peru, Spain, United Kingdom, Germany, Poland, Romania, Finland, Canada, Argentina, Australia, South Africa, Czech Republic, India, Netherlands, Italy, Switzerland, Korea, Republic of, Hungary, ... and more
-
Invitae CorporationCompleted
-
BioProtectCompletedProstate CancerUnited States, Israel, United Kingdom, Netherlands, Poland, Portugal
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada
-
Watson PharmaceuticalsCompletedProstate CancerUnited States
-
Ascenta TherapeuticsCompletedProstate CancerUnited States
-
Trans Tasman Radiation Oncology GroupCompletedNasopharyngeal Cancer | Anal Cancer | Intermediate Risk Prostate Cancer | Prostate Cancer (Post Prostatectomy)Australia
-
Novartis PharmaceuticalsCompletedProstate CancerUnited States
-
Achieve Life SciencesCompletedProstate CancerFrance, United States, Canada, Australia, Hungary, Czech Republic, Russian Federation, United Kingdom
-
AmgenCompletedProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Belgium, Austria, Singapore, Australia, Netherlands, France, Japan, Taiwan, Canada
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Terminated
-
Bavarian NordicNational Cancer Institute (NCI); Therion Biologics CorporationCompletedProstate CancerUnited States
-
Mayo ClinicNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Beth Israel Deaconess Medical CenterBristol-Myers Squibb; Dana-Farber Cancer InstituteActive, not recruitingProstate CancerUnited States
-
Janssen Scientific Affairs, LLCCompletedProstate CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingMetastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Castration-Sensitive Prostate CarcinomaUnited States
-
Incyte CorporationTerminatedProstate CancerUnited States
-
Millennium Pharmaceuticals, Inc.CompletedProstate CancerFrance, United States, Belgium, Spain, Australia, Canada, Netherlands, Italy, Poland, Czechia, Estonia, Finland, Hungary, Greece
-
POINT Biopharma, a wholly owned subsidiary of Eli...Active, not recruitingMetastatic Castration-Resistant Prostate CancerUnited States, Canada, Netherlands, Sweden, France, United Kingdom
-
Exosome Diagnostics, Inc.Completed
-
Merck Sharp & Dohme LLCRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Austria, Canada, France, Germany, Ireland, Italy, Mexico, Netherlands, New Zealand, Poland, Russian Federation, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, Spain, Finland, Australia, Denmark
-
SanofiCompletedProstate CancerKorea, Republic of, Spain, United States, Argentina, Peru, Romania, Taiwan, United Kingdom, Belgium, Chile, Netherlands, Australia, Germany, Tunisia, Brazil, Canada, France, Hungary, Poland, Russian Federation, South Africa, Turkey
-
University of ChicagoNational Cancer Institute (NCI)Completed
-
Nymox CorporationCompletedProstate CancerUnited States
-
Molecular Insight Pharmaceuticals, Inc.CompletedProstate CancerUnited States, Belgium, Italy, Czech Republic, Hungary, Netherlands, Poland, Russian Federation
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingHealthy | Prostate Cancer | Conditions Influencing Health StatusUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedProstate CancerUnited States, Canada
-
Boston Scientific CorporationAugmenix, Inc.Completed
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Czech Republic, Hungary, Romania, Canada
-
CelgeneCompletedProstate CancerUnited States, Spain, France, Belgium, Australia, Denmark, Austria, United Kingdom, Netherlands, Poland, Israel, Italy, Germany, Greece, Canada, Czechia, Hungary, Mexico, Russian Federation, South Africa, Sweden
-
AbbottCompletedProstate CancerUnited States, Canada, France, Spain, Belgium, Australia, United Kingdom, Italy, Sweden, South Africa, Netherlands, Ireland, Germany, Austria, New Zealand, Greece, Poland, Switzerland
-
Telix Pharmaceuticals (Innovations) Pty LimitedActive, not recruiting
-
GP-PharmCompletedProstate CancerUnited States, Austria, Czech Republic, Germany, Hungary, Italy, Slovakia, Spain, United Kingdom
-
LTN PHARMACEUTICALS, INC.TerminatedProstate CancerUnited States, Canada
-
Orion Corporation, Orion PharmaEndo PharmaceuticalsCompletedProstate CancerUnited States, United Kingdom, Finland, France, Czech Republic, Estonia
-
Millennium Pharmaceuticals, Inc.CompletedProstate CancerUnited States, Canada
-
Carolina Research Professionals, LLCBayerCompleted
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstate Cancer MetastaticCanada, Germany, United States, Israel, Puerto Rico, Taiwan, Korea, Republic of, Australia, Chile, China, France, Norway, Czechia, Finland, Hong Kong, Netherlands, Poland, Spain, Sweden, Turkey, Denmark, Hungary, Italy, United Kingdom
-
Innocrin PharmaceuticalProstate Cancer Foundation; Prostate Cancer Clinical Trials ConsortiumCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States, Canada
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada
-
Ferring PharmaceuticalsMemorial Sloan Kettering Cancer Center; Duke Clinical Research InstituteTerminatedProstate CancerUnited States, France, Canada, Czechia, Finland, Germany, Greece, Poland, Russian Federation, Slovakia, South Africa, United Kingdom
-
BayerActive, not recruitingMetastatic Castration-resistant Prostate CancerUnited States, Austria, Czechia, Israel, Italy, Germany, United Kingdom, France, Mexico, Belgium, Canada, Colombia, Greece, Luxembourg, Netherlands, Spain, Denmark, Sweden, Argentina, Portugal